GLP-1 Therapies Research Papers

3 weeks ago • Frontiers in endocrinology

Glucagon-like peptide-1 receptor drugs and Parkinson's disease risk in people with type 2 diabetes: a review and analysis of large patient dataGlucagon-like peptide-1 receptor agonists and the risk of Parkinson's disease in patients with type 2 diabetes: a systematic review and meta-analysis of large-scale real-world data.

🎖️ Top 10% JournalSystematic Review

1 week ago • Frontiers in endocrinology

Effects of incretin receptor drugs in patients after weight-loss surgery: a systematic review and meta-analysisUse of incretin receptor agonists in patients submitted to metabolic bariatric surgery - a systematic review and meta-analysis.

🎖️ Top 10% JournalSystematic Review

1 week ago • Frontiers in public health

Cost-effectiveness of loxenatide compared to DPP-4 inhibitors for Chinese people with type 2 diabetes and high heart disease riskCost-utility analysis of loxenatide versus DPP-4 inhibitors in Chinese patients with type 2 diabetes at high cardiovascular risk.

📖 Top 20% JournalFulltext (Open License)Comparative Study

1 week ago • PeerJ

Weight gain after stopping diabetes-related hormone treatments in overweight or obese adults: a review and analysisWeight regain following discontinuation of glucagon-like peptide-1 receptor agonists in adults who are overweight or obese: a systematic review and meta-analysis.

📖 Top 30% JournalFulltext (Open License)Systematic Review

2 weeks ago • Endocrinology, diabetes & metabolism

Patterns of Weight Regain After Stopping Semaglutide or Tirzepatide TreatmentWeight Regain Trajectories After Discontinuation of Semaglutide or Tirzepatide: A Reconstructed Aggregate-Data Bayesian Longitudinal Meta-Analysis.

📖 Top 20% JournalMeta-Analysis

3 weeks ago • Medicina (Kaunas, Lithuania)

Does the best day of the week to take Semaglutide or Tirzepatide affect their use? A review of existing studiesIs There a Better Day of the Week to Administer Semaglutide or Tirzepatide? A Systematic Literature Review.

📖 Top 30% JournalSystematic Review

3 days ago • Frontiers in endocrinology

Added benefits of SGLT2 inhibitors, GLP-1 receptor agonists, and pioglitazone for type 2 diabetes and fatty liver disease in Asian populationsIncremental effects of SGLT2 inhibitors, GLP-1 receptor agonists, and pioglitazone in type 2 diabetes and MASLD across Asian study settings: a systematic review and meta-analysis.

🎖️ Top 10% JournalSystematic Review

4 days ago • Frontiers in endocrinology

Changes in blood sugar control and weight in obese and non-obese adults with type 2 diabetes treated with SGLT-2 inhibitors or GLP-1 receptor agonistsComparative change in HbA1c and weight outcomes between obese and non-obese adults with type 2 diabetes mellitus treated with SGLT-2 inhibitors or GLP-1 receptor agonists.

🎖️ Top 10% JournalMulticenter Study

1 week ago • Frontiers in endocrinology

Lower starting blood sugar and kidney function link to less favorable body changes after SGLT2 inhibitor treatment in type 2 diabetesLow baseline HbA1c and reduced eGFR are associated with relatively unfavorable body recomposition after SGLT2 inhibitor therapy in type 2 diabetes.

🎖️ Top 10% JournalMulticenter Study

1 week ago • Frontiers in cardiovascular medicine

Glucagon-like peptide-1 receptor drugs linked to return of irregular heartbeat after heart rhythm treatmentAssociation of glucagon-like peptide-1 receptor agonists with atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis.

📖 Top 20% JournalSystematic Review

1 week ago • PloS one

Effects of GLP-1 receptor drugs on patients with precancerous pancreatic cysts: Study plan for a multi-center patient groupImpact of GLP-1 receptor agonists on patients with intraductal papillary mucinous neoplasms: Study protocol for a multicentric cohort study.

📖 Top 30% JournalMulticenter Study

2 weeks ago • Frontiers in endocrinology

Effectiveness of diabetes drugs and aerobic exercise for moderate-to-severe sleep apnea in overweight or obese patientsEfficacy of SGLT2 inhibitors, GLP-1 receptor agonists, and aerobic exercise for moderate-to-severe obstructive sleep apnea in overweight or obese patients: a network meta-analysis.

🎖️ Top 10% JournalSystematic Review

3 weeks ago • International journal of obesity (2005)

Semaglutide under the skin and its link to weight loss and inflammation in overweight adults without diabetesEffects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis.

🎖️ Top 10% JournalSystematic Review

3 weeks ago • Frontiers in medicine

Research on GLP-1 receptor drugs across the stages from fatty liver disease to liver inflammation and liver cancerMapping GLP-1 receptor agonist research across the MASLD-MASH-HCC continuum: a bibliometric and translational analysis.

📖 Top 20% JournalSystematic Review

3 weeks ago • Nutrients

Metabolic and hormone responses to large nutrient doses on a low-carb diet in a controlled studyUnderstanding the Metabolic and Endocrine Effects of Macronutrient Boluses in the Context of a Low-Carbohydrate Diet: A Randomized Crossover Study.

🎖️ Top 10% JournalRandomized Controlled Trial

3 weeks ago • Pulmonology

Use and unmet needs of GLP-1 drugs in sleep medicine across Europe: A survey from the sleep apnea networkClinical practice patterns and unmet needs in the use of GLP-1 receptor agonists in sleep medicine: A pan-European survey performed in the European sleep apnoea database network.

🎖️ Top 10% JournalMulticenter Study

3 days ago • Endocrinology, diabetes & metabolism

Comparing the Effects of Semaglutide, Liraglutide, and Tirzepatide on Heart and Metabolic HealthImpact of Semaglutide, Liraglutide and Tirzepatide on Cardiometabolic Outcomes: A Comparative Narrative Review.

📖 Top 20% JournalComparative Study

1 week ago • Endocrinology, diabetes & metabolism

Effectiveness and Safety of Tirzepatide Compared to Dulaglutide in Type 2 Diabetes With or Without Heart and Blood Vessel DiseaseEfficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials.

📖 Top 20% JournalNetwork Meta-Analysis

1 week ago • Journal of orthopaedic surgery (Hong Kong)

Use of Glucagon-like Peptide-1 Receptor Agonists Linked to Lower Risk of Joint Infection After Total Knee Replacement, Confirmed by Side-by-Side ComparisonGlucagon-like Peptide-1 receptor agonist use is associated with decreased risk of periprosthetic joint infection following total knee arthroplasty: A laterality-verified propensity matched comparison.

📖 Top 50% JournalComparative Study

2 weeks ago • Endocrinology, diabetes & metabolism

Heart and blood vessel outcomes of GLP-1 medicines compared to weight loss surgeryComparative Cardiovascular Outcomes of GLP-1 Receptor Agonists Versus Bariatric Surgery: A Systematic Review and Network Meta-Analysis.

📖 Top 20% JournalSystematic Review

2 weeks ago • Clinical obesity

Tirzepatide versus Semaglutide for Weight Loss in Adults with Overweight or Obesity: A Comparison StudyComparative Efficacy of Tirzepatide Versus Semaglutide for Weight Loss in Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis of Head-to-Head Studies.

📖 Top 30% JournalSystematic Review

3 weeks ago • Journal of obesity

Liraglutide's effectiveness in obese patients who do not respond early to lifestyle changesEffectiveness of Liraglutide in Patients With Obesity Who Are Early Non-Responders to Lifestyle Intervention: A Real-World Study.

📖 Top 20% JournalObservational Study

3 days ago • BMC endocrine disorders

Effectiveness and safety of 12 mg versus 36 mg orforglipron doses for maintaining weight in people with obesity, with or without diabetesEfficacy and safety of orforglipron 12 mg versus orforglipron 36 mg maintenance dose among patients with obesity with or without diabetes: a systematic review and comprehensive meta-analysis.

📖 Top 20% JournalSystematic Review

1 week ago • Frontiers in endocrinology

Tirzepatide may improve blood sugar control in Rabson-Mendenhall syndromeCase Report: Tirzepatide improves glycemic control in Rabson-Mendenhall syndrome.

🎖️ Top 10% JournalFulltext (Open License)Case Reports

1 week ago • Drugs

Effects of GLP-1 Receptor Agonists on Muscle and Bone Health: A Review and AnalysisGLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis.

🥈 Top 2% JournalSystematic Review

1 week ago • Journal of medical Internet research

Using Digital Support to Improve GLP-1 Drug Treatment: Focus on Staying on Treatment, Side Effects, and Lasting Benefits After StoppingDigital Behavioral Infrastructure for Glucagon-Like Peptide-1 Pharmacotherapy: Viewpoint on Persistence, Tolerability, and Postcessation Durability.

🥉 Top 5% JournalArticle

1 week ago • Journal of neurology

Nerve problems in type 2 diabetes linked to GLP-1 receptor drugs compared to DPP-4 inhibitor drugsGLP-1 receptor agonists vs DPP-4 inhibitors and neuropathic complications in type 2 diabetes.

🎖️ Top 10% JournalComparative Study

2 weeks ago • Journal of medical Internet research

Digital Use and Factors Linked to Staying on Semaglutide and Losing Weight in Severe Obesity Over 48 WeeksDigital Engagement and Predictors of Semaglutide Persistence and Weight Loss in Severe Obesity: 48-Week Observational Study.

🥉 Top 5% JournalObservational Study

2 weeks ago • Journal of primary care & community health

Awareness, Confidence, and Use of Combined GLP-1 and GIP/GLP-1 Medicines Among Healthcare Providers and PharmacistsAssessing Awareness, Confidence and Utilization of Compounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists Among Healthcare Clinicians and Pharmacists: A Comprehensive Survey Study.

📖 Top 20% JournalObservational Study

2 weeks ago • Nature communications

Heart and blood vessel outcomes of two diabetes drugs in kidney failure patients with heart failureCardiovascular outcome of glucagon-like peptide-1 receptor agonists vs dipeptidyl peptidase-4 inhibitor on end-stage kidney disease patients with heart failure: an emulated target trial in patients with diabetes.

🥈 Top 2% JournalRandomized Controlled Trial

← prevpage 1 of 14next →